Crsp stock price today

Nov 17, 2023 · 15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price. .

Get CRISPR Therapeutics AG (CRSP.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.CRSP’s price has also changed slightly for the past six months – from $61.700 to $59.220, which is a -4.02% drop . See today’s best-performing stocks on TipRanks >>

Did you know?

CRISPR Therapeutics AG (CRSP Quick Quote CRSP - Free Report) shares rallied 12.4% in the last trading session to close at $43.75.This move can be attributable to notable volume with a higher ...Discover historical prices for NFLX stock on Yahoo Finance. View daily, weekly or monthly format back to when Netflix, Inc. stock was issued.Stock Performance. CRSP stock opened at $55.44 on Friday, reflecting a fluctuation in value within a specific trading period. Over the past year, CRISPR Therapeutics has witnessed considerable price volatility within its shares, with a 1-year low of $38.94 and a 1-year high of $84.10.Dec 4, 2023 · The company, currently valued at $5.45B, closed the recent trade at $68.61 per share which meant it lost -$0.04 on the day or -0.07% during that session. The CRSP stock price is -11.05% off its 52-week high price of $76.19 and 45.27% above the 52-week low of $37.55. If we look at the company’s 10-day average daily trading volume, we find that ...

CRSP stock soared in 2021 along with many biotech stocks. But there’s been a sharp pullback since then. In fact, as of this writing, the mid-cap stock is trading below its pre-pandemic level.CRISPR Therapeutics (CRSP-2.22%) is heading for an important moment: the potential approval of its first product, exa-cel to treat blood disorders. That's a good reason to buy the stock now and ...Get the latest CRISPR Therapeutics AG (CRSP) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Like many other stocks, Editas Medicine was crushed over the last 18 months. Since the middle of 2021, EDIT plummeted from a high of about $72.50 to $8.43.Aug 8, 2023 · What happened. Shares of CRISPR Therapeutics ( CRSP -4.38%) were jumping 9.1% as of 11:31 a.m. ET on Tuesday after rising as much as 13% earlier in the day. The nice gain came after the company ...

DNA | Complete Ginkgo Bioworks Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest Akamai Technologies, Inc. (AKAM) stock quote, history, news and other vital information to help you with your stock trading and investing. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Crsp stock price today. Possible cause: Not clear crsp stock price today.

Get the latest CRISPR Therapeutics AG (CRSP) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Nov 20, 2023 · The company’s 2032 estimated earnings pegs the stock’s forward price-to-earnings ratio at just 0.4-times. Sales are expected to climb from $1.9 million to over $257 million during that timeframe.

CRSP stock is up 6.4% and CRTX stock is up 4.3% as of Tuesday morning. Investors seeking out all of the latest stock market news are in luck! We’ve got all of the hottest stock news traders need ...Find the latest Exscientia plc (EXAI) stock quote, history, news and other vital information to help you with your stock trading and investing.May 9, 2023 · Shares of the developmental gene-editing company CRISPR Therapeutics ( CRSP 4.32%) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the ...

invz stock price The company’s 2032 estimated earnings pegs the stock’s forward price-to-earnings ratio at just 0.4-times. Sales are expected to climb from $1.9 million to over $257 million during that timeframe.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading. fubo stockshow much is a gold bullion worth Sep 29, 2023 · He kept his buy rating and 88 price target on CRSP stock. ... Today, CRSP stock has a low Relative Strength Rating of 28 out of a best-possible 99, according to IBD Digital. This puts the stock's ... If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti... investment podcast for beginners A cost-effective treatment even at $2 million. Margins could look fantastic on exa-cel. Experts believe the therapy may provide so much value to patients that even at a high price tag it would ... upro etfbest performing international etfquarter dollars worth money Security-level historical pricing, returns, and volume data on more than 20000 stocks (inactive and active companies) from the NYSE, AMEX, ... freeman's restaurant new york Shares of the developmental gene-editing company CRISPR Therapeutics ( CRSP 4.32%) were up by 12.4% on sky-high volume as of 1:46 p.m. ET Tuesday afternoon. The big gain came in response to the ... high yield reits 2023presentation skills course onlineis meet beagle secure He has a sector perform rating and price target of 50 on CRSP stock. But other analysts are more bullish. ... Stock Market Today: Track Market Trends And The Best Stocks To Watch.